SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-001839
Filing Date
2019-04-01
Accepted
2019-04-01 16:48:25
Documents
109
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2238283z10-k.htm 10-K 1407084
2 EX-21.1 a2238283zex-21_1.htm EX-21.1 3142
3 EX-23.1 a2238283zex-23_1.htm EX-23.1 6936
4 EX-31.1 a2238283zex-31_1.htm EX-31.1 8196
5 EX-31.2 a2238283zex-31_2.htm EX-31.2 8157
6 EX-32.1 a2238283zex-32_1.htm EX-32.1 4732
7 EX-32.2 a2238283zex-32_2.htm EX-32.2 4679
14 G476352.JPG g476352.jpg GRAPHIC 67683
  Complete submission text file 0001047469-19-001839.txt   8073363

Data Files

Seq Description Document Type Size
8 EX-101.INS ontx-20181231.xml EX-101.INS 1734194
9 EX-101.SCH ontx-20181231.xsd EX-101.SCH 91075
10 EX-101.CAL ontx-20181231_cal.xml EX-101.CAL 57651
11 EX-101.DEF ontx-20181231_def.xml EX-101.DEF 280569
12 EX-101.LAB ontx-20181231_lab.xml EX-101.LAB 661046
13 EX-101.PRE ontx-20181231_pre.xml EX-101.PRE 518532
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 19721386
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1